nodes	percent_of_prediction	percent_of_DWPC	metapath
Flavoxate—Raloxifene—ESR1—liver cancer	0.03	1	CrCbGaD
Flavoxate—PDE4B—Signaling Pathways—PIK3CG—liver cancer	0.000403	0.000415	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—APC—liver cancer	0.000403	0.000415	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MTOR—liver cancer	0.000402	0.000415	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—PIK3CB—liver cancer	0.000402	0.000415	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—IL6—liver cancer	0.000402	0.000415	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—IL6—liver cancer	0.000402	0.000415	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—PIK3CD—liver cancer	0.000402	0.000414	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—PIK3CA—liver cancer	0.000398	0.00041	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—SERPINE1—liver cancer	0.000398	0.00041	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—KRAS—liver cancer	0.000393	0.000406	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—TP53—liver cancer	0.000392	0.000404	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CSF2—liver cancer	0.00039	0.000402	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CSF2—liver cancer	0.000385	0.000397	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—HRAS—liver cancer	0.000384	0.000396	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PIK3CD—liver cancer	0.000383	0.000394	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—PIK3CA—liver cancer	0.000379	0.000391	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—BRAF—liver cancer	0.000378	0.00039	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—SERPINE1—liver cancer	0.000378	0.00039	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CDKN1B—liver cancer	0.000378	0.000389	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—PIK3CA—liver cancer	0.000376	0.000388	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—HRAS—liver cancer	0.000375	0.000386	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—KRAS—liver cancer	0.000375	0.000386	CbGpPWpGaD
Flavoxate—PDE4C—GPCR downstream signaling—AKT1—liver cancer	0.000374	0.000385	CbGpPWpGaD
Flavoxate—PDE8A—Signaling Pathways—AKT1—liver cancer	0.000371	0.000383	CbGpPWpGaD
Flavoxate—PDE8B—Signaling Pathways—AKT1—liver cancer	0.000371	0.000383	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CASP3—liver cancer	0.00037	0.000382	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IL2—liver cancer	0.00037	0.000381	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—IL6—liver cancer	0.000368	0.000379	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—TP53—liver cancer	0.000364	0.000375	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—PIK3CA—liver cancer	0.000361	0.000373	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CCND1—liver cancer	0.00036	0.000371	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—JUN—liver cancer	0.00036	0.000371	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—RAF1—liver cancer	0.000359	0.00037	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—IL6—liver cancer	0.000359	0.00037	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ADAM17—liver cancer	0.000357	0.000368	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CTNNB1—liver cancer	0.000357	0.000368	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PIK3CD—liver cancer	0.000354	0.000365	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ADAM17—liver cancer	0.000353	0.000364	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—PIK3CA—liver cancer	0.000351	0.000361	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MTOR—liver cancer	0.00035	0.000361	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—PIK3CB—liver cancer	0.00035	0.000361	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—SERPINE1—liver cancer	0.00035	0.000361	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MMP9—liver cancer	0.00035	0.000361	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—CDKN1A—liver cancer	0.000349	0.000359	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—HRAS—liver cancer	0.000348	0.000359	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—KRAS—liver cancer	0.000347	0.000357	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—PIK3CA—liver cancer	0.000344	0.000355	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—RAF1—liver cancer	0.000342	0.000352	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MAPK8—liver cancer	0.00034	0.000351	CbGpPWpGaD
Flavoxate—PDE4C—Signaling by GPCR—AKT1—liver cancer	0.000339	0.00035	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—F2—liver cancer	0.000337	0.000347	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PSMA4—liver cancer	0.000336	0.000346	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PSMD10—liver cancer	0.000336	0.000346	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—HRAS—liver cancer	0.000334	0.000345	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MTOR—liver cancer	0.000333	0.000344	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PIK3CB—liver cancer	0.000333	0.000344	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—IL6—liver cancer	0.000333	0.000344	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—F2—liver cancer	0.000333	0.000343	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PSMA4—liver cancer	0.000332	0.000342	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PSMD10—liver cancer	0.000332	0.000342	CbGpPWpGaD
Flavoxate—PDE7B—Signaling Pathways—AKT1—liver cancer	0.000331	0.000341	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CDKN1B—liver cancer	0.000329	0.000339	CbGpPWpGaD
Flavoxate—PDE4D—GPCR downstream signaling—AKT1—liver cancer	0.000325	0.000335	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—PIK3CG—liver cancer	0.000322	0.000332	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CASP3—liver cancer	0.000322	0.000332	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IL2—liver cancer	0.000322	0.000332	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—IL6—liver cancer	0.00032	0.00033	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—PIK3CA—liver cancer	0.000318	0.000328	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—HRAS—liver cancer	0.000318	0.000328	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—PIK3CG—liver cancer	0.000318	0.000328	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—RAF1—liver cancer	0.000316	0.000326	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—VEGFA—liver cancer	0.000314	0.000324	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CCND1—liver cancer	0.000314	0.000323	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—JUN—liver cancer	0.000313	0.000323	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CDKN1B—liver cancer	0.000313	0.000323	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—STAT3—liver cancer	0.000311	0.000321	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CTNNB1—liver cancer	0.000311	0.00032	CbGpPWpGaD
Flavoxate—PDE4A—GPCR downstream signaling—AKT1—liver cancer	0.00031	0.000319	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MTOR—liver cancer	0.000309	0.000318	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PIK3CB—liver cancer	0.000309	0.000318	CbGpPWpGaD
Flavoxate—PDE7A—Signaling Pathways—AKT1—liver cancer	0.000307	0.000317	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CASP3—liver cancer	0.000307	0.000316	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IL2—liver cancer	0.000306	0.000316	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—F2—liver cancer	0.000306	0.000315	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—IL6—liver cancer	0.000305	0.000314	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MMP9—liver cancer	0.000304	0.000314	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—CDKN1A—liver cancer	0.000303	0.000313	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—F2—liver cancer	0.000302	0.000311	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CCND1—liver cancer	0.000299	0.000308	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—JUN—liver cancer	0.000298	0.000307	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MAPK8—liver cancer	0.000296	0.000305	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CTNNB1—liver cancer	0.000296	0.000305	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—AKT1—liver cancer	0.000295	0.000304	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—HRAS—liver cancer	0.000295	0.000304	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PIK3CG—liver cancer	0.000293	0.000302	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MMP9—liver cancer	0.00029	0.000299	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CDKN1B—liver cancer	0.00029	0.000298	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PIK3CG—liver cancer	0.000289	0.000298	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MYC—liver cancer	0.000289	0.000298	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CDKN1A—liver cancer	0.000289	0.000298	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TGFB1—liver cancer	0.000288	0.000297	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—AKT1—liver cancer	0.000286	0.000295	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CASP3—liver cancer	0.000284	0.000293	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—PIK3CD—liver cancer	0.000283	0.000292	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IL2—liver cancer	0.000283	0.000292	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—IL6—liver cancer	0.000282	0.000291	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MAPK8—liver cancer	0.000282	0.000291	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—AKT1—liver cancer	0.000281	0.00029	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—PIK3CD—liver cancer	0.00028	0.000288	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CCND1—liver cancer	0.000276	0.000285	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—JUN—liver cancer	0.000276	0.000284	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CTNNB1—liver cancer	0.000274	0.000282	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—VEGFA—liver cancer	0.000273	0.000282	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—STAT3—liver cancer	0.000271	0.000279	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MMP9—liver cancer	0.000268	0.000276	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CDKN1A—liver cancer	0.000267	0.000275	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—KRAS—liver cancer	0.000267	0.000275	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MAPK8—liver cancer	0.000261	0.000269	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PRKCE—liver cancer	0.00026	0.000268	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—VEGFA—liver cancer	0.00026	0.000268	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—AKT1—liver cancer	0.00026	0.000268	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—STAT3—liver cancer	0.000258	0.000266	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PIK3CD—liver cancer	0.000257	0.000265	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PRKCE—liver cancer	0.000257	0.000265	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PIK3CD—liver cancer	0.000254	0.000262	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MYC—liver cancer	0.000252	0.000259	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TGFB1—liver cancer	0.000251	0.000259	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—PIK3CB—liver cancer	0.000247	0.000255	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IGF2—liver cancer	0.000247	0.000254	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—PIK3CA—liver cancer	0.000245	0.000253	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—PIK3CB—liver cancer	0.000244	0.000251	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IGF2—liver cancer	0.000243	0.000251	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—VEGFA—liver cancer	0.000241	0.000248	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MYC—liver cancer	0.000239	0.000247	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TGFB1—liver cancer	0.000239	0.000246	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—STAT3—liver cancer	0.000238	0.000246	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TP53—liver cancer	0.000237	0.000245	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—KRAS—liver cancer	0.000232	0.00024	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CSF2—liver cancer	0.00023	0.000237	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—RAF1—liver cancer	0.00023	0.000237	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CSF2—liver cancer	0.000227	0.000234	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—HRAS—liver cancer	0.000227	0.000234	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—H2AFX—liver cancer	0.000227	0.000234	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—IL2—liver cancer	0.000227	0.000234	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—RAF1—liver cancer	0.000227	0.000234	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PIK3CB—liver cancer	0.000224	0.000231	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—H2AFX—liver cancer	0.000224	0.000231	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—IL2—liver cancer	0.000224	0.000231	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MYC—liver cancer	0.000222	0.000228	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PIK3CB—liver cancer	0.000221	0.000228	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—KRAS—liver cancer	0.000221	0.000228	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TGFB1—liver cancer	0.000221	0.000228	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IL6—liver cancer	0.000217	0.000224	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—PIK3CA—liver cancer	0.000214	0.00022	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TP53—liver cancer	0.000207	0.000213	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—IL2—liver cancer	0.000206	0.000212	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TERT—liver cancer	0.000205	0.000212	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—KRAS—liver cancer	0.000205	0.000211	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—IL2—liver cancer	0.000203	0.00021	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PIK3CA—liver cancer	0.000203	0.00021	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TERT—liver cancer	0.000203	0.000209	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—AKT1—liver cancer	0.0002	0.000207	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—HRAS—liver cancer	0.000198	0.000204	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TP53—liver cancer	0.000197	0.000203	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IL6—liver cancer	0.000189	0.000195	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PIK3CA—liver cancer	0.000188	0.000194	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—HRAS—liver cancer	0.000188	0.000194	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—KDR—liver cancer	0.000188	0.000194	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MAPK14—liver cancer	0.000186	0.000192	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—KDR—liver cancer	0.000185	0.000191	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MAPK14—liver cancer	0.000184	0.00019	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ESR1—liver cancer	0.000183	0.000189	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TP53—liver cancer	0.000182	0.000188	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—F2—liver cancer	0.000181	0.000186	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ESR1—liver cancer	0.000181	0.000186	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IL6—liver cancer	0.00018	0.000186	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—F2—liver cancer	0.000178	0.000184	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—AKT1—liver cancer	0.000174	0.00018	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—HRAS—liver cancer	0.000174	0.000179	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—APC—liver cancer	0.000173	0.000178	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PIK3CG—liver cancer	0.000173	0.000178	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—APC—liver cancer	0.000171	0.000176	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PIK3CG—liver cancer	0.000171	0.000176	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IL6—liver cancer	0.000167	0.000172	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—AKT1—liver cancer	0.000166	0.000171	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—BRAF—liver cancer	0.000163	0.000168	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—BRAF—liver cancer	0.00016	0.000165	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—AKT1—liver cancer	0.000154	0.000158	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PIK3CD—liver cancer	0.000152	0.000157	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—PIK3CA—liver cancer	0.000151	0.000155	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—SERPINE1—liver cancer	0.00015	0.000155	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PIK3CD—liver cancer	0.00015	0.000155	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—KRAS—liver cancer	0.000149	0.000153	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—PIK3CA—liver cancer	0.000149	0.000153	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—SERPINE1—liver cancer	0.000148	0.000153	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—KRAS—liver cancer	0.000147	0.000151	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PIK3CA—liver cancer	0.000137	0.000141	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—RAF1—liver cancer	0.000136	0.00014	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PIK3CA—liver cancer	0.000135	0.000139	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—RAF1—liver cancer	0.000134	0.000138	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PIK3CB—liver cancer	0.000133	0.000137	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MTOR—liver cancer	0.000133	0.000137	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MTOR—liver cancer	0.000131	0.000135	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PIK3CB—liver cancer	0.000131	0.000135	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—HRAS—liver cancer	0.000127	0.00013	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—HRAS—liver cancer	0.000125	0.000129	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CDKN1B—liver cancer	0.000124	0.000128	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—AKT1—liver cancer	0.000123	0.000127	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CDKN1B—liver cancer	0.000123	0.000127	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CASP3—liver cancer	0.000122	0.000126	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL2—liver cancer	0.000122	0.000125	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—AKT1—liver cancer	0.000121	0.000125	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—IL6—liver cancer	0.000121	0.000125	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CASP3—liver cancer	0.00012	0.000124	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL2—liver cancer	0.00012	0.000124	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—IL6—liver cancer	0.00012	0.000123	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CCND1—liver cancer	0.000119	0.000122	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—JUN—liver cancer	0.000118	0.000122	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CTNNB1—liver cancer	0.000117	0.000121	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CCND1—liver cancer	0.000117	0.000121	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—JUN—liver cancer	0.000117	0.00012	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CTNNB1—liver cancer	0.000116	0.00012	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MMP9—liver cancer	0.000115	0.000119	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CDKN1A—liver cancer	0.000115	0.000118	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MMP9—liver cancer	0.000114	0.000117	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CDKN1A—liver cancer	0.000113	0.000117	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MAPK8—liver cancer	0.000112	0.000115	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—AKT1—liver cancer	0.000112	0.000115	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MAPK8—liver cancer	0.000111	0.000114	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—AKT1—liver cancer	0.00011	0.000114	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—VEGFA—liver cancer	0.000103	0.000107	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—STAT3—liver cancer	0.000102	0.000106	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—VEGFA—liver cancer	0.000102	0.000105	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—STAT3—liver cancer	0.000101	0.000104	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MYC—liver cancer	9.52e-05	9.81e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TGFB1—liver cancer	9.49e-05	9.79e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MYC—liver cancer	9.39e-05	9.68e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TGFB1—liver cancer	9.37e-05	9.66e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—KRAS—liver cancer	8.79e-05	9.06e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—KRAS—liver cancer	8.68e-05	8.95e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PIK3CA—liver cancer	8.08e-05	8.33e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PIK3CA—liver cancer	7.97e-05	8.22e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TP53—liver cancer	7.81e-05	8.06e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TP53—liver cancer	7.71e-05	7.95e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HRAS—liver cancer	7.47e-05	7.7e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HRAS—liver cancer	7.38e-05	7.61e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL6—liver cancer	7.15e-05	7.37e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL6—liver cancer	7.06e-05	7.28e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—AKT1—liver cancer	6.6e-05	6.8e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—AKT1—liver cancer	6.51e-05	6.72e-05	CbGpPWpGaD
